These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1971648)

  • 1. Treatment of severe chronic bronchitis with ceftazidime.
    Micklefield GH; Schött D; Zimmermann I; Ulmer WT
    J Hosp Infect; 1990 Apr; 15 Suppl A():65-7. PubMed ID: 1971648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum and serum levels of amoxycillin in chronic bronchial infections.
    Ingold A
    Br J Dis Chest; 1975 Jul; 69():211-6. PubMed ID: 1201187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the protease inhibitor aprotinin on pulmonary function and on the inhibitory activity of sputum in patients with chronic obstructive bronchitis].
    Rasche B; Marcic I; Ulmer WT
    Arzneimittelforschung; 1975 Jan; 25(1):110-6. PubMed ID: 1080051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis.
    Woolhouse IS; Hill SL; Stockley RA
    Thorax; 2001 Dec; 56(12):947-53. PubMed ID: 11713358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime.
    Davies BI; Maesen FP; van Noord JA
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():1-8. PubMed ID: 6352611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ceftazidime in the therapy of chronic bronchitis relapses in elderly hospitalized patients].
    Vozza A; Crivellaro R; Panebianco R
    Clin Ter; 1991 May; 137(4):269-73. PubMed ID: 1831092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
    Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB
    Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis.
    Tamaoki J; Chiyotani A; Tagaya E; Sakai N; Konno K
    Thorax; 1994 Jun; 49(6):545-8. PubMed ID: 8016790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and sputum erythromycin concentrations in chronic bronchitis.
    Marlin GE; Davis PR; Rutland J; Berend N
    Thorax; 1980 Jun; 35(6):441-5. PubMed ID: 7434299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of ampicillin and amoxycillin in acute on chronic bronchitis.
    Anderson G; Jariwalla AG; Saour J
    Thorax; 1979 Dec; 34(6):814-6. PubMed ID: 396690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The therapeutic and diagnostic contribution of ceftazidime (Fortum) in Pseudomonas aeruginosa superinfection in a patient with chronic bronchopathy].
    Mihălţan F; Ulmeanu R; Ciprut T; Dragoş M
    Pneumoftiziologia; 1997; 46(1):53-7. PubMed ID: 9289238
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative effectiveness of tetracycline, minocycline and doxycycline in treatment of acute-on-chronic bronchitis. A study based on sputum levels.
    Ruhen RW; Tandon MK
    Med J Aust; 1976 Feb; 1(6):151-3. PubMed ID: 1083475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial of ceftazidime efficacy in respiratory infections at two dose levels.
    Feist H; Vetter N; Muhar F; Williams KJ; Brandstetter HJ; Ho I
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():299-301. PubMed ID: 19803002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to corticosteroids in chronic bronchitis.
    Shim C; Stover DE; Williams MH
    J Allergy Clin Immunol; 1978 Dec; 62(6):363-7. PubMed ID: 361794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methylprednisolone on sputum biochemical components in asthmatic bronchitis.
    Moretti M; Giannico G; Marchioni CF; Bisetti A
    Eur J Respir Dis; 1984 Jul; 65(5):365-70. PubMed ID: 6745338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction.
    Edwards GF; Steel AE; Scott JK; Jordan JW
    Chest; 1976 Oct; 70(4):506-13. PubMed ID: 789027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic therapy of acute exacerbations of chronic bronchitis. A controlled study using tetracycline.
    Nicotra MB; Rivera M; Awe RJ
    Ann Intern Med; 1982 Jul; 97(1):18-21. PubMed ID: 7092002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position of ceftazidime in respiratory diseases.
    Ando' F; Girbino G; Ferrara F
    Drugs Exp Clin Res; 1985; 11(6):369-72. PubMed ID: 3915288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
    Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema.
    Llewellyn-Jones CG; Harris TA; Stockley RA
    Am J Respir Crit Care Med; 1996 Feb; 153(2):616-21. PubMed ID: 8564107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.